---
figid: PMC6781272__pharmaceutics-11-00441-g001
figlink: /pmc/articles/PMC6781272/figure/pharmaceutics-11-00441-f001/
number: F1
caption: 'A generalized Toll-like receptor signaling mechanism, adapted from []. TLRs
  are subdivided into two main categories based on their location, cell surface or
  endosomal; they are activated by their respective PAMPs and damage-associated molecular
  patterns. After recognizing respective ligand(s) via extracellular domains, TLRs
  form homo- or heterodimers and interact with cytoplasmic adaptor molecules (myeloid
  differentiation primary response protein 88 (MyD88), TIRAP (MAL), TRIF, or TRAM)
  through their cytoplasmic TIR domain. Most of TLRs activate downstream signaling
  in a MyD88-dependent manner with or without recruiting MAL; however, TLR3 (only)
  and TLR4 (alternatively) use TRIF/TRAM adaptors to activate IRFs. The activation
  of a TLR signaling pathway leads to the translocation of transcription factors (NF-κB
  (p50 or p65), AP-1, IRF3, and IRF7) into the nucleus and allows them to bind the
  target sequence(s) of inflammatory and interferon-responsive genes. Abbreviations:
  TLR, Toll-like receptor; TIR, Toll/interleukin-1 receptor domain; MAL, MyD88 adaptor
  like; MyD88, myeloid differentiation primary response 88; TRAM, TRIF-related adaptor
  molecule; TRIF, TIR domain-containing adaptor inducing interferon β; IRAK, interleukin
  receptor-associated kinase; RIP, receptor-interacting protein; TRAF, tumor necrosis
  factor receptor (TNFR)-associated factor; TAB, TAK-1–binding protein; TAK1, transforming
  growth factor β-activated kinase 1; TBK1, TANK-binding kinase 1; NEMO, NF-κB essential
  modulator; IκB, inhibitor of κB; IKK, inhibitor of κB kinase; MAP, mitogen-activated
  protein; ERK, extracellular signal–regulated kinase; JNK, c-Jun N-terminal kinase;
  p38, protein 38; AP-1, activated protein 1; IFN, interferon; IL, interleukin; IRF,
  interferon response factor; NF-κB, nuclear factor κB; TNF-α, tumor necrosis factor
  α.'
pmcid: PMC6781272
papertitle: Toll-Like Receptors and Relevant Emerging Therapeutics with Reference
  to Delivery Methods.
reftext: Nasir Javaid, et al. Pharmaceutics. 2019 Sep;11(9):441.
pmc_ranked_result_index: '109814'
pathway_score: 0.9607897
filename: pharmaceutics-11-00441-g001.jpg
figtitle: Generalized Toll-like receptor signaling mechanism, adapted from []
year: '2019'
organisms: Homo sapiens
ndex: aecfe427-dedd-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6781272__pharmaceutics-11-00441-g001.html
  '@type': Dataset
  description: 'A generalized Toll-like receptor signaling mechanism, adapted from
    []. TLRs are subdivided into two main categories based on their location, cell
    surface or endosomal; they are activated by their respective PAMPs and damage-associated
    molecular patterns. After recognizing respective ligand(s) via extracellular domains,
    TLRs form homo- or heterodimers and interact with cytoplasmic adaptor molecules
    (myeloid differentiation primary response protein 88 (MyD88), TIRAP (MAL), TRIF,
    or TRAM) through their cytoplasmic TIR domain. Most of TLRs activate downstream
    signaling in a MyD88-dependent manner with or without recruiting MAL; however,
    TLR3 (only) and TLR4 (alternatively) use TRIF/TRAM adaptors to activate IRFs.
    The activation of a TLR signaling pathway leads to the translocation of transcription
    factors (NF-κB (p50 or p65), AP-1, IRF3, and IRF7) into the nucleus and allows
    them to bind the target sequence(s) of inflammatory and interferon-responsive
    genes. Abbreviations: TLR, Toll-like receptor; TIR, Toll/interleukin-1 receptor
    domain; MAL, MyD88 adaptor like; MyD88, myeloid differentiation primary response
    88; TRAM, TRIF-related adaptor molecule; TRIF, TIR domain-containing adaptor inducing
    interferon β; IRAK, interleukin receptor-associated kinase; RIP, receptor-interacting
    protein; TRAF, tumor necrosis factor receptor (TNFR)-associated factor; TAB, TAK-1–binding
    protein; TAK1, transforming growth factor β-activated kinase 1; TBK1, TANK-binding
    kinase 1; NEMO, NF-κB essential modulator; IκB, inhibitor of κB; IKK, inhibitor
    of κB kinase; MAP, mitogen-activated protein; ERK, extracellular signal–regulated
    kinase; JNK, c-Jun N-terminal kinase; p38, protein 38; AP-1, activated protein
    1; IFN, interferon; IL, interleukin; IRF, interferon response factor; NF-κB, nuclear
    factor κB; TNF-α, tumor necrosis factor α.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK1
  - MAPK3
  - FOSL1
  - IFNA8
  - IFNA10
  - JUND
  - IFNA16
  - IFNA17
  - IFNA21
  - IFNA1
  - IFNA2
  - IFNA4
  - IFNA5
  - IFNA6
  - IFNA7
  - TNF
  - KRR1
  - IFNA13
  - IFNA14
  - TBK1
  - TIRAP
  - MAL
  - TLR10
  - TLR2
  - TLR1
  - TLR6
  - TLR3
  - TLR4
  - TLR5
  - TLR8
  - TAB2
  - NR2C2
  - TRAF3
  - TRAF6
  - MAPK9
  - MAPK10
  - IFNB1
  - CHUK
  - IL12A
  - IL12B
  - IL6
  - CXCL8
  - IRAK1
  - TLR7
  - TLR9
  - IRF7
  - MAPK8
  - MAPK12
  - MAPK14
  - MYD88
  - IKBKG
  - FOSB
  - FOS
  - MAPK11
  - MAPK13
  - JUNB
  - FOSL2
  - JUN
  - IRF3
  - IRAK4
  - TRAM
  - TAB TAB2
genes:
- word: (ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: (ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL1
  entrez: '8061'
- word: IFNB,IFNA,IFN-induciblegenes
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA8
  entrez: '3445'
- word: IFNB,IFNA,IFN-induciblegenes
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA10
  entrez: '3446'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUND
  entrez: '3727'
- word: IFNB,IFNA,IFN-induciblegenes
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA16
  entrez: '3449'
- word: IFNB,IFNA,IFN-induciblegenes
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA17
  entrez: '3451'
- word: IFNB,IFNA,IFN-induciblegenes
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA21
  entrez: '3452'
- word: IFNB,IFNA,IFN-induciblegenes
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA1
  entrez: '3439'
- word: IFNB,IFNA,IFN-induciblegenes
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA2
  entrez: '3440'
- word: IFNB,IFNA,IFN-induciblegenes
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA4
  entrez: '3441'
- word: IFNB,IFNA,IFN-induciblegenes
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA5
  entrez: '3442'
- word: IFNB,IFNA,IFN-induciblegenes
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA6
  entrez: '3443'
- word: IFNB,IFNA,IFN-induciblegenes
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA7
  entrez: '3444'
- word: Proinflammatorycytokines:IL-6,IL-8,IL-12,TNFA
  symbol: TNF-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: RIP1
  symbol: RIP-1
  source: hgnc_alias_symbol
  hgnc_symbol: KRR1
  entrez: '11103'
- word: IFNB,IFNA,IFN-induciblegenes
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA13
  entrez: '3447'
- word: IFNB,IFNA,IFN-induciblegenes
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA14
  entrez: '3448'
- word: TBK1
  symbol: TBK1
  source: hgnc_symbol
  hgnc_symbol: TBK1
  entrez: '29110'
- word: TIRAP/MAL
  symbol: TIRAP
  source: hgnc_symbol
  hgnc_symbol: TIRAP
  entrez: '114609'
- word: TIRAP/MAL
  symbol: MAL
  source: hgnc_symbol
  hgnc_symbol: MAL
  entrez: '4118'
- word: TLR10/10
  symbol: TLR10
  source: hgnc_symbol
  hgnc_symbol: TLR10
  entrez: '81793'
- word: TLR1/2
  symbol: TLR2
  source: hgnc_symbol
  hgnc_symbol: TLR2
  entrez: '7097'
- word: TLR1/2
  symbol: TLR1
  source: hgnc_symbol
  hgnc_symbol: TLR1
  entrez: '7096'
- word: TLR2/6
  symbol: TLR6
  source: hgnc_symbol
  hgnc_symbol: TLR6
  entrez: '10333'
- word: TLR3/3
  symbol: TLR3
  source: hgnc_symbol
  hgnc_symbol: TLR3
  entrez: '7098'
- word: TLR4/4
  symbol: TLR4
  source: hgnc_symbol
  hgnc_symbol: TLR4
  entrez: '7099'
- word: TLR5/5
  symbol: TLR5
  source: hgnc_symbol
  hgnc_symbol: TLR5
  entrez: '7100'
- word: TLR7/7TLR8/8,
  symbol: TLR8
  source: hgnc_symbol
  hgnc_symbol: TLR8
  entrez: '51311'
- word: TAB2
  symbol: TAB2
  source: hgnc_symbol
  hgnc_symbol: TAB2
  entrez: '23118'
- word: TAK1
  symbol: TAK1
  source: hgnc_alias_symbol
  hgnc_symbol: NR2C2
  entrez: '7182'
- word: TRAF3
  symbol: TRAF3
  source: hgnc_symbol
  hgnc_symbol: TRAF3
  entrez: '7187'
- word: TRAF6
  symbol: TRAF6
  source: hgnc_symbol
  hgnc_symbol: TRAF6
  entrez: '7189'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: IFNB,IFNA,IFN-induciblegenes
  symbol: IFNB
  source: bioentities_symbol
  hgnc_symbol: IFNB1
  entrez: '3456'
- word: IKKA
  symbol: IKK-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: IL-12,
  symbol: IL12
  source: bioentities_symbol
  hgnc_symbol: IL12A
  entrez: '3592'
- word: IL-12,
  symbol: IL12
  source: bioentities_symbol
  hgnc_symbol: IL12B
  entrez: '3593'
- word: IL-6,
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: IL-8,
  symbol: IL-8
  source: hgnc_alias_symbol
  hgnc_symbol: CXCL8
  entrez: '3576'
- word: IRAK1
  symbol: IRAK1
  source: hgnc_symbol
  hgnc_symbol: IRAK1
  entrez: '3654'
- word: TLR7/7TLR8/8,
  symbol: TLR7
  source: hgnc_symbol
  hgnc_symbol: TLR7
  entrez: '51284'
- word: TLR9/9
  symbol: TLR9
  source: hgnc_symbol
  hgnc_symbol: TLR9
  entrez: '54106'
- word: IRF7
  symbol: IRF7
  source: hgnc_symbol
  hgnc_symbol: IRF7
  entrez: '3665'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: (p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: (p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: MYD88
  symbol: MYD88
  source: hgnc_symbol
  hgnc_symbol: MYD88
  entrez: '4615'
- word: NEMO
  symbol: NEMO
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSB
  entrez: '2354'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: (p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: (p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUNB
  entrez: '3726'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL2
  entrez: '2355'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: IRF3
  symbol: IRF3
  source: hgnc_symbol
  hgnc_symbol: IRF3
  entrez: '3661'
- word: IRAK4
  symbol: IRAK4
  source: hgnc_symbol
  hgnc_symbol: IRAK4
  entrez: '51135'
chemicals:
- word: TRAM
  source: MESH
  identifier: C411671
- word: TAB TAB2
  source: MESH
  identifier: C417682
diseases: []
figid_alias: PMC6781272__F1
redirect_from: /figures/PMC6781272__F1
figtype: Figure
---
